Massachusetts Financial Services
BBIO icon

Massachusetts Financial Services’s BridgeBio Pharma BBIO Stock Holding History

Massachusetts Financial Services’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$240K Sell
3,231
-84
-3% -$6.09K ﹤0.01% 934
2025
Q4 		$254K Buy
+3,315
New +$218K ﹤0.01% 903
2024
Q4 		– Sell
-737,367
Closed -$18.8M – 880
2024
Q3 		$18.8M Buy
737,367
+139,104
+23% +$3.65M 0.01% 600
2024
Q2 		$15.2M Buy
598,263
+219,257
+58% +$5.99M ﹤0.01% 605
2024
Q1 		$11.7M Buy
+379,006
New +$12.9M ﹤0.01% 615
2021
Q4 		– Sell
-441,288
Closed -$20.7M – 892
2021
Q3 		$20.7M Sell
441,288
-5,844
-1% -$313K 0.01% 611
2021
Q2 		$27.3M Sell
447,132
-1,285
-0.3% -$73.4K 0.01% 582
2021
Q1 		$27.6M Buy
448,417
+25,481
+6% +$1.67M 0.01% 573
2020
Q4 		$30.1M Buy
422,936
+7,811
+2% +$377K 0.01% 547
2020
Q3 		$15.6M Sell
415,125
-10,196
-2% -$321K 0.01% 592
2020
Q2 		$13.9M Buy
425,321
+32,613
+8% +$993K 0.01% 583
2020
Q1 		$11.4M Buy
392,708
+78,754
+25% +$2.44M 0.01% 576
2019
Q4 		$11M Buy
313,954
+96
+0% +$2.66K ﹤0.01% 592
2019
Q3 		$6.74M Sell
313,858
-36,142
-10% -$1,000K ﹤0.01% 638
2019
Q2 		$9.44M Buy
+350,000
New +$9.54M ﹤0.01% 628

Other funds holding BBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services's BBIO Position: Q1 2026 in Review

Massachusetts Financial Services reduced its BridgeBio Pharma (BBIO) stake by 2.5% in Q1 2026, selling an estimated $6.09K and leaving 3,231 shares worth $240K. The position accounts for ﹤0.01% of the portfolio, ranked #934.

Massachusetts Financial Services first reported a position in BBIO in Q2 2019 and has held it in 15 quarters since. The position peaked at $30.1M in Q4 2020. 457 funds tracked by Wall St. Rank hold BBIO as of Q1 2026.

  • Massachusetts Financial Services held 3,231 shares of BridgeBio Pharma worth $240K as of Q1 2026.
  • Massachusetts Financial Services sold 84 BridgeBio Pharma shares in Q1 2026, an estimated $6.09K.
  • BridgeBio Pharma made up ﹤0.01% of Massachusetts Financial Services's portfolio in Q1 2026, its #934 holding.
  • Massachusetts Financial Services first reported a position in BridgeBio Pharma in Q2 2019 and has held it in 15 quarters since.
  • Massachusetts Financial Services's BridgeBio Pharma position peaked at $30.1M in Q4 2020.
  • 457 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q1 2026.

Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.